Health Care Vendor Interactions: Difference between revisions

no edit summary
No edit summary
No edit summary
Line 17: Line 17:
</table>
</table>
<br />
<br />
[[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Copyright]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Trial Fee Billing Procedures]] | [[Contracts Policy]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use & Transfer]] | [[International Research Policy]] | [[Health Care Vendor Interactions Policy]] ] [Internal Audit]
[[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Copyright]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Trial Fee Billing Procedures]] | [[Contracts Policy]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use & Transfer]] | [[International Research Policy]] | [[Health Care Vendor Interactions Policy]] | [[Internal Audit]]
<br /><br />Policy No.: '''8015'''<br />
<br /><br />Policy No.: '''8015'''<br />
Effective Date: '''DRAFT'''<br />
Effective Date: '''DRAFT'''<br />